NA
Nordwand Advisors’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.57M | Buy |
46,166
+45,684
| +9,478% | +$8.48M | 1.34% | 15 |
|
2025
Q1 | $101K | Hold |
482
| – | – | 0.04% | 34 |
|
2024
Q4 | $85.7K | Hold |
482
| – | – | 0.04% | 40 |
|
2024
Q3 | $95.2K | Sell |
482
-1,400
| -74% | -$276K | 0.03% | 37 |
|
2024
Q2 | $323K | Sell |
1,882
-5,013
| -73% | -$860K | 0.14% | 20 |
|
2024
Q1 | $1.26M | Sell |
6,895
-12,295
| -64% | -$2.24M | 0.49% | 20 |
|
2023
Q4 | $2.97M | Buy |
19,190
+68
| +0.4% | +$10.5K | 0.78% | 18 |
|
2023
Q3 | $2.85M | Sell |
19,122
-3,283
| -15% | -$489K | 0.56% | 16 |
|
2023
Q2 | $3.02M | Sell |
22,405
-148
| -0.7% | -$19.9K | 0.52% | 19 |
|
2023
Q1 | $3.59M | Sell |
22,553
-34,021
| -60% | -$5.42M | 0.59% | 16 |
|
2022
Q4 | $9.14M | Buy |
+56,574
| New | +$9.14M | 1.14% | 9 |
|